Topics

Michael Wong is an Emeritus Board Member of the Harvard Business School Healthcare Alumni Association.

Articles

Harvard Business School’s Robert S. Kaplan, co-inventor of the Balanced Scorecard offers three guiding principles of M&A execution excellence.

M&A: Three Guiding Principles of Execution Excellence

Expansion features 11 new cGMP labs at Durham, NC location

Cambrex Grows Its Biopharma Offerings

A chat with Cardinal Health’s Joel Wayment, who dives into what can be done to help ensure that patients receive their necessary medications, no matter the conditions 

Combatting Inclement Weather in the Midst of Supply Chain Preservation

The parties are partnering up to leverage dedicated commercial fill-finish manufacturing capacity in the US for mRNA vaccines and therapies

Moderna and Thermo Fisher Scientific Form Long-Term Strategic Manufacturing Collaboration

Turnkey centers will promote scalable vaccine production for an end-to-end manufacturing network for mRNA-based vaccines in Africa

BioNTech to Build Modular mRNA Manufacturing Facilities in Africa

CDMO obtains both Vibalogics and Arranta Bio to increase presence in the sector

A Productive Day: Recipharm Completes Two Biologics Deals

Will establish presence in Belgium, Denmark, Norway, the Netherlands, Poland and Sweden

Moderna to Grow European Commercial Footprint

Agreement provides pharma firms with an RWD and commercialization solution

Eversana, Thread Collaborate on Decentralized Registry Deal

Publication finds that only about 40% of retail pharmacists feel equipped to discuss biosimilars with patients 

Cardinal Health Releases 2022 Biosimilars Report

Michael Christel is Group Managing Editor of Pharmaceutical Commerce, Pharmaceutical Executive, and Applied Clinical Trials. He can be reached at mchristel@mjhlifesciences.com.

A conversation with Michael Abrams, co-founder and managing partner,  Numerof & Associates

Business and Finance